Literature DB >> 25568296

Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study.

Aleksandra Pikula1, Alexa S Beiser2, Jing Wang2, Jayandra J Himali2, Margaret Kelly-Hayes2, Carlos S Kase2, Qiong Yang2, Sudha Seshadri2, Philip A Wolf2.   

Abstract

OBJECTIVES: To examine the relationship between plasma lipid measurements and incident ischemic vascular events (ischemic stroke [IS], and as a positive control, myocardial infarction [MI]) in a community cohort.
METHODS: In 6,276 stroke-free Framingham participants (aged 64 ± 10 years, 56% female), we related plasma lipid levels (total cholesterol [TC], high-density lipoprotein cholesterol [HDL-C], and TC/HDL-C ratio) measured at the original cohort 15th (1977-1979) and 20th examination cycles (1986-1990) and (TC, HDL-C, TC/HDL-C ratio, triglycerides [TG], and low-density lipoprotein cholesterol [LDL-C]) measured at the offspring fourth examination (1995-1998), to 10-year risk of incident IS and MI. Utilizing genome-wide genotyping in the same subjects, we used mendelian randomization methods to assess whether observed associations were incidental or causal.
RESULTS: During a mean follow-up of 9 years, 301 participants experienced incident IS. In multivariable-adjusted analyses, HDL-C ≤40 mg/dL and TC/HDL ratio ≥5 were associated with increased risk of IS (hazard ratio [95% confidence interval]: 1.59 [1.23-2.05], p < 0.001 and 1.47 [1.15-1.87], p < 0.001), but not TC or LDL-C. In adjusted analysis, a strong association between TG and IS was diminished. In the MI-free sample (n = 5,875, aged 64 ± 10 years, 58% female; 403 MI events), all lipid markers were associated with MI risk. A genetic risk score comprising 47 known determinants of circulating HDL-C was not associated with IS.
CONCLUSIONS: In a middle-aged to elderly community sample, we observed that low HDL-C and high TC/HDL-C ratio, but not LDL-C or TG were associated with risk of incident IS. We observed the usual associations between lipids and risk of MI. Our findings suggest an important, but less likely causal, role of HDL-C over other lipid biomarkers for optimal stroke risk stratification.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25568296      PMCID: PMC4336066          DOI: 10.1212/WNL.0000000000001202

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Polymorphisms associated with cholesterol and risk of cardiovascular events.

Authors:  Sekar Kathiresan; Olle Melander; Dragi Anevski; Candace Guiducci; Noël P Burtt; Charlotta Roos; Joel N Hirschhorn; Göran Berglund; Bo Hedblad; Leif Groop; David M Altshuler; Christopher Newton-Cheh; Marju Orho-Melander
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

2.  Epidemiological approaches to heart disease: the Framingham Study.

Authors:  T R DAWBER; G F MEADORS; F E MOORE
Journal:  Am J Public Health Nations Health       Date:  1951-03

3.  Comparison of serum lipid values in patients with coronary artery disease at <50, 50 to 59, 60 to 69, and >70 years of age.

Authors:  Protásio L da Luz; Fernando H Y Cesena; Desidério Favarato; Eliana S Cerqueira
Journal:  Am J Cardiol       Date:  2005-10-21       Impact factor: 2.778

Review 4.  High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review.

Authors:  Pierre Amarenco; Julien Labreuche; Pierre-Jean Touboul
Journal:  Atherosclerosis       Date:  2007-10-17       Impact factor: 5.162

5.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

6.  Multiple biomarkers for the prediction of first major cardiovascular events and death.

Authors:  Thomas J Wang; Philimon Gona; Martin G Larson; Geoffrey H Tofler; Daniel Levy; Christopher Newton-Cheh; Paul F Jacques; Nader Rifai; Jacob Selhub; Sander J Robins; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2006-12-21       Impact factor: 91.245

7.  Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups.

Authors:  D L Tirschwell; N L Smith; S R Heckbert; R N Lemaitre; W T Longstreth; B M Psaty
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

8.  Lipid levels and the risk of ischemic stroke in women.

Authors:  T Kurth; B M Everett; J E Buring; C S Kase; P M Ridker; J M Gaziano
Journal:  Neurology       Date:  2007-02-20       Impact factor: 9.910

9.  Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Authors:  Pierre Amarenco; Larry B Goldstein; Michael Szarek; Henrik Sillesen; Amy E Rudolph; Alfred Callahan; Michael Hennerici; Lisa Simunovic; Justin A Zivin; K Michael A Welch
Journal:  Stroke       Date:  2007-10-25       Impact factor: 7.914

10.  Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.

Authors: 
Journal:  Lancet       Date:  1995 Dec 23-30       Impact factor: 79.321

View more
  24 in total

Review 1.  Role of Improved Vascular Health in the Declining Incidence of Dementia.

Authors:  Matthew P Pase; Claudia L Satizabal; Sudha Seshadri
Journal:  Stroke       Date:  2017-06-08       Impact factor: 7.914

2.  Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke.

Authors:  Xiao-Wu Hong; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng; Wen-Jun Tu; Jing Yan
Journal:  Mol Neurobiol       Date:  2016-12-21       Impact factor: 5.590

Review 3.  Nucleic Acid Therapies for Ischemic Stroke.

Authors:  Nils Henninger; Yunis Mayasi
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

Review 4.  Guidelines for Management of Hyperlipidemia: Implications for Treatment of Patients with Stroke Secondary to Atherosclerotic Disease.

Authors:  Sudeepta Dandapat; Jennifer G Robinson
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

5.  Primary hyperlipidemia with associated ischemic strokes in a West Highland white terrier dog.

Authors:  Stephen Everest; Gibrann Castillo; Luis Gaitero
Journal:  Can Vet J       Date:  2020-10       Impact factor: 1.008

6.  The associations of lipids and lipid ratios with stroke: A prospective cohort study.

Authors:  Xiaojuan Liu; Ling Yan; Fuzhong Xue
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-11-21       Impact factor: 3.738

7.  PCSK9 Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke: Data From 9 Studies of Blacks and Whites.

Authors:  Shia T Kent; Robert S Rosenson; Christy L Avery; Yii-Der I Chen; Adolfo Correa; Steven R Cummings; L Adrienne Cupples; Mary Cushman; Daniel S Evans; Vilmundur Gudnason; Tamara B Harris; George Howard; Marguerite R Irvin; Suzanne E Judd; J Wouter Jukema; Leslie Lange; Emily B Levitan; Xiaohui Li; Yongmei Liu; Wendy S Post; Iris Postmus; Bruce M Psaty; Jerome I Rotter; Monika M Safford; Colleen M Sitlani; Albert V Smith; James D Stewart; Stella Trompet; Fangui Sun; Ramachandran S Vasan; J Michael Woolley; Eric A Whitsel; Kerri L Wiggins; James G Wilson; Paul Muntner
Journal:  Circ Cardiovasc Genet       Date:  2017-08

Review 8.  Current Applications of Genetic Risk Scores to Cardiovascular Outcomes and Subclinical Phenotypes.

Authors:  Jennifer A Smith; Erin B Ware; Pooja Middha; Lisa Beacher; Sharon L R Kardia
Journal:  Curr Epidemiol Rep       Date:  2015

9.  Apolipoprotein A1-Unique Peptide as a Diagnostic Biomarker for Acute Ischemic Stroke.

Authors:  Xu Zhao; Yue Yu; Wenlong Xu; Lei Dong; Yuan Wang; Bing Gao; Guangyu Li; Wentao Zhang
Journal:  Int J Mol Sci       Date:  2016-03-28       Impact factor: 5.923

10.  Intense Walking Exercise Affects Serum IGF-1 and IGFBP3.

Authors:  TaeHo Kim; Jae Seung Chang; Hanul Kim; Kwang Ho Lee; In Deok Kong
Journal:  J Lifestyle Med       Date:  2015-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.